Evaluating subject-level incremental values of new markers for risk classification rule

Lifetime Data Analysis

Volumn 19, Issue 4, 2013, Pages 547-567

  Cai, T ^a   Tian, L ^b   Lloyd Jones, D ^c   Wei, L J ^a  

^a HARVARD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Coronary heart disease; Nonparametric functional estimation; Risk factors markers and pointwise; Simultaneous confidence intervals; Subgroup analysis

Indexed keywords

ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN;

AGED; ARTICLE; BIOSTATISTICS; BLOOD; CONFIDENCE INTERVAL; CORONARY ARTERY DISEASE; EVALUATION STUDY; FEMALE; HUMAN; NONPARAMETRIC TEST; RISK; RISK FACTOR; UNITED STATES;

AGED; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; BIOSTATISTICS; C-REACTIVE PROTEIN; CONFIDENCE INTERVALS; CORONARY DISEASE; FEMALE; HUMANS; RISK; RISK FACTORS; STATISTICS, NONPARAMETRIC; UNITED STATES;

EID: 84886585591     PISSN: 13807870     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10985-013-9272-6     Document Type: Article

References (28)

1. Bickel PJ, Rosenblatt M (1973) On some global measures of the deviations of density function estimates. The Annals of Statistics 1: 1071-1095.
2. Buring J, Hennekens C (1992) The Women's Health Study: summary of the study design. Journal of Myocardial Ischemia 4: 27-9.
3. Chi Y, Zhou X (2008) The need for reorientation toward cost-effective prediction: Comments on 'Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond' by Pencina et al. (2008). Statistics in Medicine 27(2): 182-184.
4. Cook N (2007) Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115(7): 928.
5. Cook N (2008) Comments on 'Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond' by Pencina et al. (2008). Statistics in Medicine 27(2): 191-195.
6. Cook NR, Buring JE, Ridker P (2006) The effect of including c-reactive protein in cardiovascular risk prediction models for women. Annals of Internal Medicine 145: 21-29.
7. D'Agostino R (2006) Risk prediction and finding new independent prognostic factors. Journal of Hypertension 24(4): 643.
8. Davison A, Hinkley D (1997) Bootstrap Methods and Their Application. Cambridge Univ Pr.,.
9. Fan J, Gijbels I (1996) Local polynomial modelling and its applications, Vol. 66 of Monographs on Statistics and Applied Probability. Chapman Hall, London.
10. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A (1991) The Cardiovascular Health Study: design and rationale. Annals of Epidemiology 1(3): 263-76.
11. Greenland P (2008) Comments on 'Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond' by Pencina et al. (2008). Statistics in Medicine 27(2): 188-190.
12. Grundy S, Cleeman J et al (2004) Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Journal of the American College of Cardiology 44(3): 720-732.
13. Mealiffe M, Stokowski R, Rhees B, Prentice R, Pettinger M, Hinds D (2010) Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information. J Natl Cancer Inst 102: 1618-1627.
14. Mosca L, Appel L, Benjamin E, Berra K, Chandra-Strobos N, Fabunmi R, Grady D, Haan C, Hayes S, Judelson Dea (2004) Evidence-based guidelines for cardiovascular disease prevention in women (American Heart Association). Circulation 109(5): 672-693.
15. Mosca L, Banka CL, Benjamin ELJea (2007) Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update (for the expert panel/writing group). Circulation 115: 1481-1501.
16. Park B, Kim W, Ruppert D, Jones M, Signorini D, Kohn R (1997) Simple transformation techniques for improved non-parametric regression. Scandinavian journal of statistics 24(2): 145-163.
17. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS (2008) Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Statistics in Medicine 27(2): 157-72.
18. Pepe M, Feng Z, Huang Y, Longton G, Prentice R, Thompson I, Zheng Y (2008) Integrating the predictiveness of a marker with its performance as a classifier. American Journal of Epidemiology 167(3): 362.
19. Pepe M, Janes H, Longton G, Leisenring W, Newcomb P (2004) Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. American Journal of Epidemiology 159(9): 882-890.
20. Ridker P, Buring J, Rifai N, Cook N (2007) Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the reynolds risk score. Journal of the American Medical Association 297: 611-9.
21. Tian L, Cai T, Goetghebeur E, Wei LJ (2007) Model evaluation based on the sampling distribution of estimated absolute prediction error. Biometrika 94(2): 297.
22. Uno H, Cai T, Tian L, Wei LJ (2007) Evaluating prediction rules for t-Year survivors with censored regression models. Journal of the American Statistical Association 102(478): 527-537.
23. van der Vaart A, Wellner J (1996) Weak Convergence and Empirical Processes. Springer,.
24. Waholder S, Hartge P, Prentice R et al (2010) Performance of common genetic variants in breast-cancer risk models. New England Journal of Medicine 362: 986-993.
25. Wand M, Jones M (1995) Kernel Smoothing. Chapman & Hall/CRC,.
26. Wand MP, Marron JS, Ruppert D (1991) Transformation in density estimation (with comments). Journal of the American Statistical Association 86: 343-361.
27. Wang T, Gona P et al (2006) Multiple biomarkers for the prediction of first major cardiovascular events and death. New England Journal of Medicine 355(25): 2631.
28. Wilson P, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97: 1837-47.